Federal prosecutors say a Detroit clinic network pushed over 500,000 opioid doses for cash, moving millions through shell companies.
Story Highlights
- Five people, including three doctors, were indicted in Detroit on opioid and money-laundering charges.
- Prosecutors allege cash-only visits, $250–$500 fees, and recruiters paying people to get prescriptions.
- The indictment cites over 500,000 doses of Schedule II opioids between 2021 and 2024.
- Officials link the cash flow to two companies tied to the alleged clinic operator.
Who Was Charged and What Prosecutors Allege
The U.S. Attorney’s Office for the Eastern District of Michigan announced charges against Clara Wilkerson, Latanya Wallace-Hardiman, and physicians Luis Rodriguez, Nayantara Jnananand, and Prashanti Franklin. Prosecutors say the group conspired to illegally distribute controlled substances and launder the profits from 2018 through September 2024. The government alleges Wilkerson used CRW Worldwide, LLC and CRW Development, Inc. to recruit and pay doctors, while Wallace-Hardiman owned and ran the Woodward Boulevard Medical Building in Detroit.
The three doctors allegedly worked at the Detroit clinic and issued prescriptions that fell outside usual medical practice. The indictment focuses on common street opioids: oxycodone 30 milligram, oxymorphone 40 milligram, hydrocodone-acetaminophen, and oxycodone-acetaminophen 10-325. Prosecutors say the clinic refused insurance and took cash only. Reporting based on the filing states the clinic charged $250 to $500 per visit and collected the fee when patients got the requested prescription. An indictment is a charge, not proof of guilt.
How the Alleged “Cash for Pills” Model Worked
Prosecutors describe a fixed-fee model joined with high-dose opioids and patient recruitment. Reports say recruiters paid people $100 or more to seek scripts, while the clinic took cash and sent patients out with written orders for Schedule II drugs. Officials estimate that from 2021 to 2024, more than 500,000 dosage units were prescribed, with a street value above $4.6 million, according to the Department of Justice release. This pattern mirrors past “pill-mill” cases built on cash-only care and large volumes of opioids.
The money-laundering counts target the cash stream that allegedly flowed through CRW Worldwide, LLC and CRW Development, Inc.. Prosecutors allege millions in cash moved from the clinics into bank deposits and transfers tied to those businesses. The case fits a federal playbook: show links between clinic owners, physicians, and cash revenue, then connect that money to companies that handle deposits and payments. The structure aims to prove both illegal prescribing and the concealment of profits.
Why This Case Matters Beyond Detroit
This indictment highlights a shared fear across the political map: powerful networks profit while families face addiction and loss. Federal authorities have brought similar cases for years, arguing that cash-only clinics and set visit fees signal abuse of medical power. In one earlier case, a physician and a manager were convicted for pushing over 600,000 opioid pills for cash, showing juries can accept this model as criminal when the evidence is strong.
For communities, the stakes are local and personal. Cash-for-prescription schemes push pills into neighborhoods, add strain on police and health workers, and deepen distrust in systems meant to protect public health. For taxpayers, alleged laundering means money moves in the shadows while the public covers the fallout. For patients with real pain, bad actors make care harder to find. Courts will test the facts here, but the policy debate on prevention, oversight, and treatment will continue.
Sources:
townhall.com, justice.gov, beckersasc.com, medboundtimes.com
